We are live on ! Find out more
VP

Vitruvian Partners Portfolio holdings

AUM $112M
1-Year Est. Return 2.02%
This Fund
S&P 500
This Quarter Est. Return
-37.57%
1 Year Est. Return
+2.02%
3 Year Est. Return
+35.84%
5 Year Est. Return
+18.92%
10 Year Est. Return
AUM
$590M
AUM Growth
-$353M
Cap. Flow
+$3.24M
Cap. Flow %
0.55%
Top 10 Hldgs %
100%
Holding
8
New
Increased
1
Reduced
Closed

Top Buys

Rank Stock Value
1
MXCT icon
MaxCyte
MXCT
+$3.24M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 58.66%
2 Technology 32.65%
3 Industrials 4.65%
4 Healthcare 4.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLBE icon
1
Global E Online
GLBE
$6.4B
$319M 54.06%
15,806,204
MQ icon
2
Marqeta
MQ
$1.84B
$87.3M 14.81%
2,691,546
WKME
3
DELISTED
WalkMe Ltd. Ordinary Shares
WKME
$60M 10.17%
5,921,122
AYX
4
DELISTED
Alteryx Inc
AYX
$39.7M 6.73%
819,547
FTCH
5
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
$27.4M 4.65%
3,829,474
CARG icon
6
CarGurus
CARG
$3.16B
$27.1M 4.6%
1,261,219
MXCT icon
7
MaxCyte
MXCT
$133M
$23.9M 4.05%
5,043,356
+657,686
+15% +$3.24M
API
8
Agora
API
$331M
$5.55M 0.94%
844,105

Similar funds

Vitruvian Partners's Q2 2022 Portfolio in Review

As of Q2 2022, Vitruvian Partners held 8 positions worth $590M, down 37% from $942M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2022: portfolio turnover was 0%. Vitruvian Partners opened no new positions and made no exits, leaving the 8-position portfolio largely intact.

By sector, the portfolio is most concentrated in Consumer Discretionary at 59% of assets, down from 62% a quarter earlier, followed by Technology and Industrials.

  • Vitruvian Partners added most to MaxCyte in Q2 2022, an estimated $3.24M increase.
  • Vitruvian Partners's ten largest holdings make up 100% of its $590M portfolio in Q2 2022.
  • Vitruvian Partners opened 0 new positions and closed 0 in Q2 2022.
  • Vitruvian Partners's portfolio value fell 37% quarter-over-quarter to $590M.

Based on Vitruvian Partners's 13F filing for Q2 2022, filed 14 Jul 2022.